Atomera Provides Third Quarter 2025 Results

Rhea-AI Summary

Atomera (NASDAQ:ATOM) reported third-quarter 2025 results and a corporate update on Oct. 28, 2025.

Key highlights: a record number of MST wafers processed for customers; a capital equipment partnership beginning to show results; and the hiring of Wei Na as Vice President of Sales. The company said its collaboration with STMicroelectronics did not progress as hoped but yielded technical insights and credibility.

Financials: net loss of $5.6M (−$0.17/share) vs. $4.6M a year earlier; adjusted EBITDA loss $4.4M vs. $3.9M; cash and short-term investments of $20.3M vs. $26.8M at Dec. 31, 2024; 31.5M shares outstanding. A live results webinar was scheduled for Oct. 28, 2025 at 2:00 p.m. PT.

Positive

• Record number of MST wafers processed for customers
• Capital equipment partnership starting to show results
• Hired Wei Na, VP of Sales, with 18 years IP licensing experience

Negative

• Net loss of $5.6M in Q3 2025 versus $4.6M in Q3 2024
• Adjusted EBITDA loss of $4.4M in Q3 2025 versus $3.9M prior year
• Cash and short-term investments down to $20.3M from $26.8M at Dec. 31, 2024

Insights

Financial operations analyst

Q3 shows operational traction but continued losses and declining cash—mixed near‑term financial picture.

Revenue drivers appear implied by a "record number of MST wafers processed" and a partnership producing results, which signal increasing customer validation for the licensing model and early commercialization activity. The company reported a net loss of ($5.6) million in Q3 Sept. 30, 2025, wider than ($4.6) million in the prior-year quarter, and adjusted EBITDA loss of ($4.4) million versus ($3.9) million year‑ago, showing losses persist despite operational progress.

Cash declined to $20.3 million from $26.8 million at year-end, which reduces the operational runway absent new licensing receipts or financing. Watch near‑term conversion of pipeline into license or commercialization agreements and any commentary in the live webinar on timing of license revenue; the next 1–3 quarters will be most informative.

Commercial licensing and technology expert

Technical validation and sales hire strengthen commercialization prospects but material revenue remains unreported.

The announcement of a record number of MST wafers processed and a capital equipment partnership beginning to show results suggests technical reproducibility and early ecosystem adoption for the licensing model. The newly hired VP of Sales with 18 years in IP licensing aims to accelerate conversion of pipeline into license and commercialization agreements but no license revenues or deal terms were disclosed.

Key dependencies include successful closing of license agreements and timing of recorded license revenue; management notes collaboration with STMicroelectronics did not progress as hoped but yielded technical insights. Monitor the live webcast on Oct. 28, 2025 and subsequent quarterly filings for explicit license revenues, payment schedules, and any changes to cash guidance over the next 2–4 quarters.

LOS GATOS, CA / ACCESS Newswire / October 28, 2025 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the third quarter ended Sept. 30, 2025.

Recent Company Highlights

• Record number of MST wafers processed for customers

• Partnership with capital equipment partner starting to show results

• Announced hiring of Wei Na as Vice President of Sales

Management Commentary

"While our collaboration with STMicroelectronics did not progress as we had hoped, it provided valuable technical insights and market credibility that continue to strengthen Atomera's customer engagements," said Scott Bibaud, President and CEO of Atomera. "We are now seeing broader interest than ever in MST across multiple segments including GAA, DRAM, RFSOI and power. Wei Na's deep semiconductor experience, including 18 years in IP licensing, comes at the perfect time. His proven leadership, deep understanding of the IP licensing landscape, and extensive relationships with leading foundries and IDMs will help us accelerate the conversion of this strong pipeline into license and commercialization agreements."

Financial Results

The Company incurred a net loss of ($5.6) million, or ($0.17) per basic and diluted share in the third quarter of 2025, compared to a net loss of ($4.6) million, or ($0.17) per basic and diluted share, for the third quarter of 2024. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2025 was a loss of ($4.4) million compared to an adjusted EBITDA loss of ($3.9) million in the third quarter of 2024.

The Company had $20.3 million in cash, cash equivalents and short-term investments as of Sept. 30, 2025, compared to $26.8 million as of December 31, 2024.

The total number of shares outstanding was 31.5 million as of September 30, 2025.

Third Quarter 2025 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, Oct. 28, 2025
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com

Note about Non-­GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology^™ (MST^®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics' decision not proceed with qualification of MST in its BCD 110 process inhibits our ability to reach commercialization with ST or other customers, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a high-volume manufacturing license with our JDA customers; (4) risks related to our ability to advance non-recurring engineering fee engagement and integration licenses to R&D and high-volume manufacturing licenses or our ability to add other customers; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and know­how and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on March 4, 2025. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow -

Atomera Incorporated
Condensed Balance Sheets
(in tHousands, except per share data)

		September 30,				June 30,				December 31,
		2025				2025				2024
		(Unaudited)				(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents		$	20,322			$	22,026			$	25,778
Short-term investments			-				-				995
Accounts receivable			137				-				6
Interest receivable			64				63				73
Prepaid expenses and other current assets			517				659				240
Total current assets			21,040				22,748				27,092
Property and equipment, net			51				50				59
Long-term prepaid maintenance and supplies			-				30				91
Security deposit			14				14				14
Operating lease right-of-use asset			92				155				280
Financing lease right-of-use-asset			744				1,087				1,588
Total assets		$	21,941			$	24,084			$	29,124
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable		$	617			$	665			$	492
Accrued expenses			244				207				239
Accrued payroll related expenses			1,112				649				1,328
Current operating lease liability			64				124				260
Current financing lease liability			730				1,148				1,253
Deferred revenue			144				-				4
Total current liabilities			2,911				2,793				3,576
Long-term operating lease liability			-				-				22
Long-term financing lease liability			-				-				449
Total liabilities			2,911				2,793				4,047
Commitments and contingencies			-				-				-
Stockholders' equity:
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of September 30, 2025, June 30, 2025 and December 31, 2024
Common stock: $0.001 par value, authorized 47,500 shares; 31,510 shares issued and outstanding as of September 30, 2025: 31,090 shares issued and outstanding as of June 30, 2025,; and 30,540 shares issued and outstanding as of December 31, 2024			32				31				31
Additional paid-in capital			256,267				252,956				246,565
Other comprehensive income(loss)			-				-				1
Accumulated deficit			(237,269	)			(231,696	)			(221,520	)
Total stockholders' equity			19,030				21,291				25,077
Total liabilities and stockholders' equity		$	21,941			$	24,084			$	29,124

Atomera Incorporated
Condensed Statements of Operations
(Unaudited)
(in thousands, except per share data)

		Three Months Ended												Nine Months Ended
		September 30,				June 30,				September 30,				September 30,
		2025				2025				2024				2025					2024
Revenue		$	11			$	-			$	22			$	15			$	112
Cost of revenue			(128	)			(62	)			(3	)			(190	)			(110	)
Gross margin			(117	)			(62	)			19				(175	)			2
Operating expenses
Research and development			3,304				3,004				2,759				9,563				8,206
General and administrative			2,165				2,048				1,812				6,301				5,455
Selling and marketing			207				141				248				472				805
Total operating expenses			5,676				5,193				4,819				16,336				14,466
Loss from operations			(5,793	)			(5,255	)			(4,800	)			(16,511	)			(14,464	)
Other income (expense)
Interest income			232				234				176				736				566
Accretion income			-				-				59				6				152
Interest expense			(12	)			(18	)			(30	)			(51	)			(104	)
Other income, net			-				72				-				71				72
Total other income (expense), net			220				288				205				762				686
Net loss		$	(5,573	)		$	(4,967	)		$	(4,595	)		$	(15,749	)		$	(13,778	)
Net loss per common share, basic and diluted		$	(0.17	)		$	(0.17	)		$	(0.17	)		$	(0.51	)		$	(0.52	)
Weighted average number of common shares outstanding, basic and diluted			31,128				30,397				27,406				30,593				26,640

Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)

		Three Months Ended												Nine Months Ended
		September 30,				June 30,				September 30,				September 30,
		2025				2025				2024				2025				2024
Net loss (GAAP)		$	(5,573	)		$	(4,967	)		$	(4,595	)		$	(15,749	)		$	(13,778	)
Depreciation and amortization			11				12				12				35				42
Stock-based compensation			1,342				1,278				907				3,629				2,918
Interest income			(232	)			(234	)			(176	)			(736	)			(566	)
Accretion income			-				-				(59	)			(6	)			(152	)
Interest expense			12				18				30				51				104
Other income, net			-				(72	)			-				(71	)			(72	)
Net loss non-GAAP EBITDA		$	(4,440	)		$	(3,965	)		$	(3,881	)		$	(12,847	)		$	(11,504	)

Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com

SOURCE: Atomera, Inc

View the original press release on ACCESS Newswire

FAQ

What were Atomera's reported Q3 2025 net loss and EPS (NASDAQ:ATOM)?

Atomera reported a net loss of $5.6M, or $0.17 per basic and diluted share for Q3 2025.

How much cash did Atomera (ATOM) have as of Sept. 30, 2025?

Atomera had $20.3M in cash, cash equivalents and short-term investments as of Sept. 30, 2025.

What did Atomera announce about production and partnerships on Oct. 28, 2025?

The company announced a record number of MST wafers processed and said a capital equipment partnership is beginning to show results.

Who did Atomera hire as VP of Sales and why does it matter for ATOM investors?

Atomera hired Wei Na, who has 18 years in IP licensing; management said this experience may help convert pipeline into licenses and commercialization agreements.

Did Atomera provide guidance or adjusted EBITDA for Q3 2025 (ATOM)?

Atomera reported an adjusted EBITDA loss of $4.4M for Q3 2025; no forward revenue guidance was provided in the announcement.

When and where was Atomera's Q3 2025 results webinar for investors?

The live webinar was scheduled for Oct. 28, 2025 at 2:00 p.m. PT and accessible via the company's investor relations webcast.